Hypomagnesemia induces impaired glucose metabolism and insulin resistance in patients with Gitelman syndrome
Authors' conclusion
Hypomagnesemia may contribute to increased BMI, exacerbating impaired glucose metabolism and IR in GS patients.
Study context
- Population
- Patients with Gitelman syndrome, with non-functioning adrenal incidentaloma (NFAI) patients as controls; clinical data and oral glucose tolerance tests (OGTT)
- Participants
- 44 vs 60
- Comparison
- Gitelman syndrome (GS) vs NFAI controls
- GSn = 44
- NFAIn = 60reference
- Outcome
- Impaired glucose metabolism and its contributing factors
Main finding
As reported in the abstract
- GS vs NFAI: P < 0.001
- GS vs NFAI: all P < 0.001
- GS vs NFAI: P = 0.003
- GS vs NFAI: P = 0.007
Observational data: associations, not effects.
Further findings
| Outcome | P value |
|---|---|
| Slope of linear regression between BMI and HOMA-IRSteeper slope with GS | P = 0.016 |
Risk factors for dysregulated glucose metabolism in GS (logistic regression)
- Hypomagnesemia
- P = 0.042
- Hypokalemia
- P = 0.046
Contributors to insulin resistance
- Higher body mass index (BMI)
- P = 0.016
- Hypomagnesemia
- P = 0.045
Correlation between plasma magnesium and BMI in GS
- Negative linear correlation, R
- 0.54
- P
- P < 0.001
Original publication
Hypomagnesemia induces impaired glucose metabolism and insulin resistance in patients with Gitelman syndrome. Diabetes Res Clin Pract. Published 29 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →